ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

March 22, 1985

CCOP Reviewers Briefed On Program Objective, Criteria

January 7, 1983

NCI Awards 41.5 Million for DES Study

February 28, 1975

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Experts Claim Errors in Breast Cancer Study, Demand Retraction of Practice-Changing Paper

May 18, 2012